Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01524991
What this trial is testing

First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Hoosier Cancer Research Network 36
Not applicableStudy completedNCT00105560
What this trial is testing

Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma

Who this might be right for
Brain and Central Nervous System TumorsLong-term Effects Secondary to Cancer Therapy in Children
Massachusetts General Hospital 59
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT00002559
What this trial is testing

Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

Who this might be right for
Ovarian CancerTesticular Germ Cell Tumor
Memorial Sloan Kettering Cancer Center 43
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Not applicableLooking for participantsNCT07551050
What this trial is testing

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 300
Large-scale testing (Phase 3)UnknownNCT00567580
What this trial is testing

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,792
Testing effectiveness (Phase 2)WithdrawnNCT01479946
What this trial is testing

Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin

Who this might be right for
Breast CancerSkin Metastases
Uppsala University Hospital
Large-scale testing (Phase 3)Ended earlyNCT00256776
What this trial is testing

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Who this might be right for
Multiple Myeloma
European Society for Blood and Marrow Transplantation 269
Not applicableStudy completedNCT01301417
What this trial is testing

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

Who this might be right for
Diverticulum, ColonColorectal NeoplasmsCrohn Disease+8 more
novoGI 171
Large-scale testing (Phase 3)Study completedNCT03802240
What this trial is testing

Sintilimab ± IBI305 Plus Chemotherapy (Pemetrexed + Cisplatin) for EGFRm + Locally Advanced or Metastasis Non-Squamous NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 492
Testing effectiveness (Phase 2)Study completedNCT00006013
What this trial is testing

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fox Chase Cancer Center 21
Not applicableUnknownNCT02999750
What this trial is testing

EXtendedAnalysis for Cancer Treatment

Who this might be right for
Malignant Solid Tumor
Medical University of Vienna 55
Testing effectiveness (Phase 2)Study completedNCT01562990
What this trial is testing

Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second Relapse

Who this might be right for
Diffuse Large B-Cell Lymphoma
The Lymphoma Academic Research Organisation 11
Very early researchWithdrawnNCT02699723
What this trial is testing

Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer

Who this might be right for
Skin Basal Cell Carcinoma
Jean Yuh Tang
Not applicableUnknownNCT06230250
What this trial is testing

Unilateral Secondary Breast Reconstruction Using a Muscle-sparing Pedicled Dorsal Flap After Breast Cancer

Who this might be right for
Patient Satisfaction
University Hospital, Brest 22
Testing effectiveness (Phase 2)Study completedNCT00407303
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Who this might be right for
Mantle-Cell Lymphoma
Gemin X 24
Testing effectiveness (Phase 2)Study completedNCT02499003
What this trial is testing

GOAL: GA101 Plus Pixantrone for Relapsed Aggressive Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Johannes Gutenberg University Mainz 70
Large-scale testing (Phase 3)Study completedNCT00040742
What this trial is testing

Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer

Who this might be right for
NauseaVomiting
Gary Morrow 745
Testing effectiveness (Phase 2)Temporarily pausedNCT02026362
What this trial is testing

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

Who this might be right for
Hepatocellular Carcinoma
HRYZ Biotech Co. 100
Next Page